Your browser doesn't support javascript.
loading
Implementation and evaluation of medicine and therapeutic information service by clinical pharmacists in oncology care setting.
Patel, Himanshu; Gurumurthy, Parthasarathi.
Afiliação
  • Patel H; Department of Pharmacy Practice, 75532 JSS College of Pharmacy , Jagadguru Sri Shivarathreeshwara University, Mysore, India.
  • Gurumurthy P; Department of Pharmacy Practice, 75532 JSS College of Pharmacy , Jagadguru Sri Shivarathreeshwara University, Mysore, India.
J Oncol Pharm Pract ; 25(1): 60-67, 2019 Jan.
Article em En | MEDLINE | ID: mdl-28841101
ABSTRACT

BACKGROUND:

This study was conducted to explore the role of clinical pharmacists in providing medicine and therapeutic information service in oncology care setting.

METHODS:

It was a prospective study conducted for a period of three years after implementation of medicine and therapeutic information service as an integral part of oncology pharmacy services. The medicine and therapeutic information queries were received during ward rounds, at ambulatory care and via telephone by clinical pharmacists. All the medicine and therapeutic information requests were reviewed and answered to the concerned requester(s). Answered medicine and therapeutic information requests were electronically documented in the hospital drug information database and analyzed further.

RESULTS:

A total of 484 medicine and therapeutic information requests were received by clinical pharmacists during period of August 2013 to June 2016. Majority of medicine and therapeutic information queries were requested by radiation oncologists (27.2%) followed by medical oncologists (26.4%), general physicians (14.04%), resident medical officers (11.7%), ambulatory care nurses (8.6%), in-patient nurses (5.1%) and patients and care takers (6.6%). Majority of the medicine and therapeutic information queries were asked for the purpose of improving patient care (48.3%) followed by to update knowledge (30.9%) and training sessions to nurses (6.6%). The most common categories of medicine and therapeutic information were adverse drug reactions and its management (21.4%) followed by dosage adjustments of chemotherapy and biologicals (15.5%), supportive care related (14.6%), contraindications (14%), drug-drug interactions (11.9%), management of co-morbidities (7.8%), chemotherapy selection in special populations (4.5%).

CONCLUSION:

The provision of medicine and therapeutic information was found to be useful in providing medicine information to improve patient care and to update knowledge of health care professionals at the study hospital.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serviço de Farmácia Hospitalar / Disseminação de Informação / Serviços de Informação sobre Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Oncologia Tipo de estudo: Diagnostic_studies / Evaluation_studies / Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serviço de Farmácia Hospitalar / Disseminação de Informação / Serviços de Informação sobre Medicamentos / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Oncologia Tipo de estudo: Diagnostic_studies / Evaluation_studies / Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Índia